BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 23670191)

  • 1. Propofol inhibits superoxide production, elastase release, and chemotaxis in formyl peptide-activated human neutrophils by blocking formyl peptide receptor 1.
    Yang SC; Chung PJ; Ho CM; Kuo CY; Hung MF; Huang YT; Chang WY; Chang YW; Chan KH; Hwang TL
    J Immunol; 2013 Jun; 190(12):6511-9. PubMed ID: 23670191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioactive secondary metabolites of a marine Bacillus sp. inhibit superoxide generation and elastase release in human neutrophils by blocking formyl peptide receptor 1.
    Yang SC; Lin CF; Chang WY; Kuo J; Huang YT; Chung PJ; Hwang TL
    Molecules; 2013 Jun; 18(6):6455-68. PubMed ID: 23736784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propofol inhibits endogenous formyl peptide-induced neutrophil activation and alleviates lung injury.
    Chen CY; Tsai YF; Huang WJ; Chang SH; Hwang TL
    Free Radic Biol Med; 2018 Dec; 129():372-382. PubMed ID: 30312762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Honokiol suppresses formyl peptide-induced human neutrophil activation by blocking formyl peptide receptor 1.
    Liu FC; Yu HP; Syu YT; Fang JY; Lin CF; Chang SH; Lee YT; Hwang TL
    Sci Rep; 2017 Jul; 7(1):6718. PubMed ID: 28751674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Garcinia Multiflora Inhibits FPR1-Mediated Neutrophil Activation and Protects Against Acute Lung Injury.
    Tsai YF; Yang SC; Chang WY; Chen JJ; Chen CY; Chang SH; Hwang TL
    Cell Physiol Biochem; 2018; 51(6):2776-2793. PubMed ID: 30562761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dipeptide HCH6-1 inhibits neutrophil activation and protects against acute lung injury by blocking FPR1.
    Yang SC; Chang SH; Hsieh PW; Huang YT; Ho CM; Tsai YF; Hwang TL
    Free Radic Biol Med; 2017 May; 106():254-269. PubMed ID: 28232203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional selective FPR1 signaling in favor of an activation of the neutrophil superoxide generating NOX2 complex.
    Lind S; Dahlgren C; Holmdahl R; Olofsson P; Forsman H
    J Leukoc Biol; 2021 Jun; 109(6):1105-1120. PubMed ID: 33040403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randialic acid B and tomentosolic acid block formyl peptide receptor 1 in human neutrophils and attenuate psoriasis-like inflammation in vivo.
    Korinek M; Hsieh PS; Chen YL; Hsieh PW; Chang SH; Wu YH; Hwang TL
    Biochem Pharmacol; 2021 Aug; 190():114596. PubMed ID: 33964283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of C-terminal phosphorylation sites of N-formyl peptide receptor-1 (FPR1) in human blood neutrophils.
    Maaty WS; Lord CI; Gripentrog JM; Riesselman M; Keren-Aviram G; Liu T; Dratz EA; Bothner B; Jesaitis AJ
    J Biol Chem; 2013 Sep; 288(38):27042-27058. PubMed ID: 23873933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The potential impacts of formyl peptide receptor 1 in inflammatory diseases.
    Yang SC; Hwang TL
    Front Biosci (Elite Ed); 2016 Jun; 8(3):436-49. PubMed ID: 27100350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 4-Aroyl-3-hydroxy-5-phenyl-1H-pyrrol-2(5H)-ones as N-formyl peptide receptor 1 (FPR1) antagonists.
    Kirpotina LN; Schepetkin IA; Khlebnikov AI; Ruban OI; Ge Y; Ye RD; Kominsky DJ; Quinn MT
    Biochem Pharmacol; 2017 Oct; 142():120-132. PubMed ID: 28690139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide length and folding state govern the capacity of staphylococcal β-type phenol-soluble modulins to activate human formyl-peptide receptors 1 or 2.
    Kretschmer D; Rautenberg M; Linke D; Peschel A
    J Leukoc Biol; 2015 Apr; 97(4):689-97. PubMed ID: 25724390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The immunosuppressant cyclosporin A antagonizes human formyl peptide receptor through inhibition of cognate ligand binding.
    Yan P; Nanamori M; Sun M; Zhou C; Cheng N; Li N; Zheng W; Xiao L; Xie X; Ye RD; Wang MW
    J Immunol; 2006 Nov; 177(10):7050-8. PubMed ID: 17082621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The non-steroidal anti-inflammatory drug piroxicam blocks ligand binding to the formyl peptide receptor but not the formyl peptide receptor like 1.
    Stenfeldt AL; Karlsson J; Wennerås C; Bylund J; Fu H; Dahlgren C
    Biochem Pharmacol; 2007 Oct; 74(7):1050-6. PubMed ID: 17692291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The proteolytically stable peptidomimetic Pam-(Lys-βNSpe)6-NH2 selectively inhibits human neutrophil activation via formyl peptide receptor 2.
    Skovbakke SL; Heegaard PM; Larsen CJ; Franzyk H; Forsman H; Dahlgren C
    Biochem Pharmacol; 2015 Jan; 93(2):182-95. PubMed ID: 25462815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting formyl peptide receptor 1 with anteiso-C13-surfactin for neutrophil-dominant acute respiratory distress syndrome.
    Yang SC; Wang YH; Ho CM; Tsai YF; Sung PJ; Lin TE; Hwang TL
    Br J Pharmacol; 2023 Aug; 180(16):2120-2139. PubMed ID: 36929355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AZ2158 is a more potent formyl peptide receptor 1 inhibitor than the commonly used peptide antagonists in abolishing neutrophil chemotaxis.
    Forsman H; Wu Y; Mårtensson J; Björkman L; Granberg KL; Dahlgren C; Sundqvist M
    Biochem Pharmacol; 2023 May; 211():115529. PubMed ID: 37004778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antagonism of human formyl peptide receptor 1 with natural compounds and their synthetic derivatives.
    Schepetkin IA; Khlebnikov AI; Kirpotina LN; Quinn MT
    Int Immunopharmacol; 2016 Aug; 37():43-58. PubMed ID: 26382576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of the formyl peptide receptor 1 (FPR1) gene in primary human macrophages.
    Gemperle C; Schmid M; Herova M; Marti-Jaun J; Wuest SJ; Loretz C; Hersberger M
    PLoS One; 2012; 7(11):e50195. PubMed ID: 23185575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological profile of a bifunctional ligand of the formyl peptide receptor1 fused to the myc epitope.
    Charest-Morin X; Roy C; Fernandes MJ; Marceau F
    Int Immunopharmacol; 2015 Mar; 25(1):229-34. PubMed ID: 25681283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.